Best Recession Proof Stocks this April 2026

Costco currently offers a modest dividend yield of 0.55%, alongside impressive returns of 5.02% over the past year and a remarkable 176.82% over the last five years. Analysts maintain a positive outlook, with a median 12-month price target of $1,100 and several firms rating the stock as "Outperform" or "Overweight." Long-term forecasts suggest that Costco's share price could nearly double by 2030, highlighting its strong growth potential.

Analysts predict Costco's share price could rise to nearly $1,050, potentially doubling by 2030.

Yes, over the past five years, Costco has returned approximately 220%, compared to 82% for the S&P 500, and over the past decade, it has returned 679% versus the S&P 500's 291%.

With a solid dividend yield of 2.66% and a 1-year return of 6.64%, this stock demonstrates stable performance for income-focused investors. Over the past five years, it has delivered an impressive total return of 40.08%. Analysts maintain a positive outlook, with a median 12-month price target of $85.00 and ratings ranging from Buy to Overweight.

To earn $1,000 annually in dividends from Coca-Cola, you would need to own approximately 472 shares, given its dividend yield of 2.84%.

In five years, Coca-Cola is expected to maintain its stable operations, which appeals to investors seeking reliability in a rapidly changing economy.

Johnson & Johnson (JNJ) remains a strong contender in the healthcare sector, bolstered by its reputation for inelastic demand in pharmaceuticals and a top-tier credit rating. With a solid dividend yield of 2.11% and impressive returns of 48.29% over the past year, it’s an attractive option for income-focused investors. Analysts have a median 12-month price target of $220, reflecting confidence in the company's stability and growth potential.

The highest closing price for Johnson & Johnson stock was $248.56 on March 2, 2026, while the 52-week high is $251.71.

Warren Buffett first traded Johnson & Johnson stock in Q1 2006, buying shares twelve times and selling them ten times before completely divesting between Q2 2012 and Q3 2023.

JNJ stock is facing challenges due to legal uncertainties, revenue declines from loss of drug exclusivity, MedTech headwinds, and broader market volatility.

Procter & Gamble (PG) remains a strong contender in the consumer staples sector, boasting a remarkable 69-year streak of dividend payments. With a current dividend yield of 2.82%, the stock's performance has been underwhelming, reflecting a 1-year return of -15.15% amid a market shift towards private label brands. Analysts have a consensus rating of Buy, with a median price target of $172.50, indicating confidence in PG's long-term value despite recent challenges.

P&G has a consensus rating of 'Buy' from 15 analysts, with 33% recommending a 'Strong Buy' and 40% a 'Buy'.

P&G's stock is declining due to a market trend favoring store brands over name brands.

Analysts predict a price target for P&G stock at $169.45, with estimates ranging from a minimum of $150.00 to a maximum of $186.00.

P&G has an average rating of 'Moderate Buy' from analysts, with a consensus target price of $168.33.